ISMRM23 - ISMRT Multilingual Session: Spanish/English

ISMRM & ISMRT Annual Meeting & Exhibition • 03-08 June 2023 • Toronto, ON, Canada

ISMRT Multilingual Session: Spanish/English

ISMRT Education Session

ORGANIZERS: Huijun (Vicky) Liao, Cristian Montalba Zalaquett

Sunday, 04 June 2023

Constitution Hall 107

15:45 - 16:45

Moderators: Cristian Montalba Zalaquett

Skill Level: Basic to Advanced

Session Number: ISMRT-MS5

No CME/CE Credit

Session Number: ISMRT-MS5

Overview
This session will be given in Spanish and will discuss the advanced ASL research and techniques, PET/MRI application and challenges, and clinical abdominal MR techniques.

English version presentations are available online.

Target Audience
Radiographers, MR technologists, radiologists, clinicians, and scientists.

Educational Objectives
As a result of attending this course, participants should be able to:
- Explain advanced ASL MR research and techniques;
- Identify PET/MRI clinical applications and challenges; and
- Recall abdominal MR techniques.

15:45		ASL Clinical Applications & Implementation View Presentation Video Sergio Solis-Barquero Keywords: Contrast mechanisms: Perfusion, Body: Body The objective of this talk is to introduce and provide an overview of the current state-of-the-art of ASL applications in the human body. The talk will focus on the research in perfusion studies in kidneys, lungs, heart, liver, pancreas, and spleen. The talk will describe ongoing challenges and recommendations that aim to enable more widespread use of the technique in clinical practice and its eventual implementation. Upon attendance, the audience should have a basic understanding of the techniques used for ASL body perfusion imaging.
16:05		Overview & Current Applications of PET/MR View Presentation Video Claudia Ortega Mogilevich
16:25		Added Value of Gadoxetic Acid-enhanced MRI in the Assessment of Focal and Diffuse Liver Disease View Presentation Video Cecilia Besa Keywords: Body: Liver Gadoxetic acid (GA) is a liver-specific MRI contrast agent that has been introduced for the diagnostic work-up of chronic diffuse liver disease and focal liver lesions combining dynamic contrast-enhanced (CE) and hepatobiliary phase imaging (HBP). For the assessment of focal liver lesions, this agent offers the possibility of distinguishing focal nodular hyperplasia (FNH) from hepatic adenoma (HA), the identification of early hepatocellular carcinoma (HCC) and the pre-operative assessment of metastasis in the liver parenchyma.The hepatic GA uptake, a reflection of liver function, correlates with chronic diffuse liver disease severity, and its use for assessing liver and biliary function is under active investigation. Abbreviated protocols for gadoxetic acid–enhanced MRI offer potential time and cost savings, but more evidence is necessary.